Wastewater reuse is a popular practice in some regions of the world, affected by water shortages. After purification techniques, wastewater can be used in several areas of irrigation and industry. Only, there are international standards declared by the World Health Organization for these waters discharged from the sewage plant. In this research, we tried to evaluate these purified wastewaters by choosing the wastewater treatment plant of Bouira. We took samples of raw water and purified water to perform common physico-chemical analyses such as (pH, turbidity, temperature, BOD5, and conductivity), whose purpose is to control the quality of water before and after treatment. This control operation lasted one month (February and March) of the year 2022. The results of the physico-chemical parameters of raw wastewater and treated wastewater are analyzed and compared with the thresholds set by the wastewater treatment plant of Bouira. At the end, we have shown that the treated water does not practically meet the standards of discharge, because the values of the physico-chemical parameters and the parameters of pollution exceed the standards, which does not encourage their reuse.
Fréquentation du registre français des essais cliniques en cancérologie et information recherchée par les patients et prochesPatients' willingness to be informed about cancer clinical trials
Le soutien public à la recherche clinique en cancérologie en France passe par des appels à projets ou candidatures compétitifs. Les projets de recherche sont financés par le Programme hospitalier de recherche clinique national en cancérologie principalement ou, pour les essais cliniques précoces de molécules innovantes, par l'Institut national du cancer (INCa) et la Fondation ARC pour la recherche sur le cancer dans le cadre d'un programme spécifique et dédié. Le soutien à l'organisation de la recherche clinique concerne notamment des réseaux de centres, d'investigateurs et de personnels de recherche clinique, et la diffusion de l'information : centres labellisés d'essais cliniques pré-coces, intergroupes coopérateurs labellisés, financement par le ministère de la Santé d'équipes mobiles de recherche clinique composées de personnels d'attachés de recherche clinique et de techniciens d'études cliniques aidant au recrutement des patients dans les essais cliniques. L'information des publics sur les essais cliniques en cours en France est faite à travers le registre des essais cliniques en cancérologie de l'INCa, consultable gratuitement sur son site internet. Ce soutien est renforcé dans le Plan cancer 2014-2019.Mots clés Cancer · Programme hospitalier de recherche clinique · Groupes coopérateurs · Centres labellisés d'essais cliniques précoces · Équipes mobiles de recherche clinique · Registre des essais cliniques en cancérologie Abstract In France, public support to clinical research in cancer is implemented through calls for competitive proposals. Research projects are funded by, mainly, the National hospital clinical research programme for cancer of the French Ministry of Health and, for early phase clinical trials of innovative molecules, by a dedicated programme of the French National Cancer Institute (INCa) and a charity, the Fondation ARC pour la recherche. Support to clinical research organisation is provided to networks of centres, investigators and teams: early clinical phase centres and cooperative intergroups, both designated by INCa, mobile clinical research teams comprising clinical research assistants and clinical trials technicians contributing to patients recruitment in clinical trials, and the registry of cancer research clinical trials conducted in France and freely accessible on INCa's website. This support is reinforced in the 2014-2019 National Control Cancer Plan.Keywords Cancer · National hospital clinical research programme · Cooperative groups · Early clinical phase designated centres · Mobile clinical research teams · Cancer research clinical trials registry L'organisation et le soutien à la recherche clinique publique en cancérologie (in partie IV : Soutenir l'innovation scientifique en cancérologie) Organisation and support to public clinical research in cancer (in part IV: Supporting scientific innovation in oncology)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.